Now showing items 1-3 of 3
-
The in vitro and in vivo pharmacokinetic parameters of polylactic–co–glycolic acid nanoparticles encapsulating anti–tuberculosis drugs
(North-West University, 2012)Tuberculosis (TB) is an infectious, deadly disease, caused by Mycobacterium tuberculosis (M.tb). In 2010, there were 8,8 million incident cases of TB globally. South Africa currently has the third highest TB incident ... -
Nano & micro-delivery systems : the Pheroid® story / Anne Frederica Grobler
(2013)For a drug to have a therapeutic effect, it has to reach its site of action in sufficient quantities. The Pheroid® delivery system enhances the absorption of various pharmacological compounds and biological molecules. The ... -
Use of natural gums and mucilages as pharmaceutical excipients
(Bentham Science, 2015)Polysaccharide rich gums and mucilages are produced by different natural sources such as plants, animals and microbial organisms to fulfil structural and physiological functions. Their diverse structural compositions with ...
